BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9104941)

  • 1. Significance of AgNOR counts for distinguishing carcinoma from adenoma and hyperplasia in parathyroid gland.
    Kanematsu E; Matsui H; Deguchi T; Yamamoto O; Korematsu M; Kobayashi A; Nezasa SI; Yamamoto N; Takeuchi T; Tanaka T; Kawada Y
    Hum Pathol; 1997 Apr; 28(4):421-7. PubMed ID: 9104941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nucleolar organizer regions of benign pathology of the parathyroids].
    Colecchia M; Zucchi A; Prian E; Leopardi O
    Pathologica; 1993; 85(1100):667-77. PubMed ID: 8170716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Argyrophil organizer region proteins (AgNORs) in adenohypophysial cells and adenomas of the human pituitary.
    Stefaneanu L; Horvath E; Kovacs K
    Mod Pathol; 1989 May; 2(3):192-9. PubMed ID: 2474815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardized in situ AgNOR analysis in breast pathology: diagnostic and cell kinetic implications.
    Bànkfalvi A; Ofner D; Schmid KW; Schmitz KJ; Breukelmann D; Krech R; Böcker W
    Pathol Res Pract; 1999; 195(4):219-29. PubMed ID: 10337659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleolar organizer regions (NOR) in hyperplastic and neoplastic prostate disease.
    Deschênes J; Weidner N
    Am J Surg Pathol; 1990 Dec; 14(12):1148-55. PubMed ID: 2252105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study.
    Vasef MA; Brynes RK; Sturm M; Bromley C; Robinson RA
    Mod Pathol; 1999 Apr; 12(4):412-6. PubMed ID: 10229506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantitative study on nucleolar organizer regions in salivary gland tumours].
    Wang SZ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1992 Mar; 27(2):74-6, 127. PubMed ID: 1337733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of p53 immunoexpression in parathyroid hyperplasias secondary to uremia, primary hyperplasias, adenomas and carcinomas.
    Kayath MJ; Martin LC; Vieira JG; Roman LM; Nosé-Alberti V
    Eur J Endocrinol; 1998 Jul; 139(1):78-83. PubMed ID: 9703382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis and P53, Bcl-2 and Bax gene expression in parathyroid glands of patients with hyperparathyroidism.
    Szende B; Farid P; Végso G; Perner F; Kopper L
    Pathol Oncol Res; 2004; 10(2):98-103. PubMed ID: 15188026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein.
    Erickson LA; Jin L; Wollan P; Thompson GB; van Heerden JA; Lloyd RV
    Am J Surg Pathol; 1999 Mar; 23(3):288-95. PubMed ID: 10078919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary gland tumours studied by means of the AgNOR technique.
    Morgan DW; Crocker J; Watts A; Shenoi PM
    Histopathology; 1988 Nov; 13(5):553-9. PubMed ID: 2463964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleolar organizer regions in normal, hyperplastic and neoplastic parathyroid glands.
    Boquist LL
    Virchows Arch A Pathol Anat Histopathol; 1990; 417(3):237-41. PubMed ID: 1696764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships of parathyroid hormone, parathyroid secretory protein, parathyroid hormone messenger RNA, parathyroid secretory protein mRNA, and replication in human parathyroid adenoma and secondary hyperplasia tissues and cultures.
    Weber CJ; Russell J; Costanzo MK; Karp F; Benjamin M; Hardy MA; Feind CR
    Surgery; 1992 Dec; 112(6):1089-94; discussion 1094-5. PubMed ID: 1455310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reticulin staining pattern in the differential diagnosis of benign parathyroid lesions.
    Kuşku Çabuk F; Sar M; Canoğlu D; Dural C; Güneş ME
    J Endocrinol Invest; 2020 Nov; 43(11):1571-1576. PubMed ID: 32242287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An improved system for quantifying AgNOR and PCNA in canine tumors.
    Hung LC; Pong VF; Cheng CR; Wong FI; Chu RM
    Anticancer Res; 2000; 20(5A):3273-80. PubMed ID: 11062753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine needle aspiration cytology combined with argyrophilic nucleolar organizer regions (AgNORs) in diagnosis of thyroid neoplasms.
    Szot W; Szybiński Z; Zaczek M; Kedra D; Dabroś E; Piotrowska K; Chłap Z
    Endokrynol Pol; 1993; 44(4):413-26. PubMed ID: 7519978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathology of parathyroid glands: Practical aspects for routine pathological investigations].
    Sheu-Grabellus SY; Schmid KW
    Pathologe; 2015 May; 36(3):229-36. PubMed ID: 25898935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of parathyroid transcription factor Gcm2 expression in parathyroid lesions.
    Nonaka D
    Am J Surg Pathol; 2011 Jan; 35(1):145-51. PubMed ID: 21164298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of argyrophilic nucleolar organizer regions (AgNORs) and mitotic index in distinguishing benign from malignant canine smooth muscle tumors and in separating inflammatory hyperplasia from neoplastic lesions of the urinary bladder mucosa.
    Johnson GC; Miller MA; Ramos-Vara JA
    J Vet Diagn Invest; 1995 Jan; 7(1):127-36. PubMed ID: 7779947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal carcinoma and its precursors: role of argyrophilic nucleolar organizer regions (AgNORs).
    Bufo P; Frassanito F; Maiorano E
    Boll Soc Ital Biol Sper; 1992 Feb; 68(2):129-36. PubMed ID: 1324695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.